Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 41
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Morris, Gerwyn Berk, Michael Galecki, Piotr Walder, Ken and Maes, Michael 2016. The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases. Molecular Neurobiology, Vol. 53, Issue. 2, p. 1195.

    Roomruangwong, Chutima Kanchanatawan, Buranee Sirivichayakul, Sunee Mahieu, Boris Nowak, Gabriel and Maes, Michael 2016. Lower Serum Zinc and Higher CRP Strongly Predict Prenatal Depression and Physio-somatic Symptoms, Which All Together Predict Postnatal Depressive Symptoms. Molecular Neurobiology,

    Roomruangwong, Chutima Kanchanatawan, Buranee Sirivichayakul, Sunee Anderson, George Carvalho, André F. Duleu, Sebastien Geffard, Michel and Maes, Michael 2016. IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome. Molecular Neurobiology,

    Anderson, G. Berk, M. and Maes, M. 2014. Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome. Acta Psychiatrica Scandinavica, Vol. 129, Issue. 2, p. 83.

    Kampling, Hanna Baumeister, Harald Jäckel, Wilfried H Mittag, Oskar and Kampling, Hanna 2014. Cochrane Database of Systematic Reviews.

    Anders, Sherry Tanaka, Midori and Kinney, Dennis K. 2013. Depression as an evolutionary strategy for defense against infection. Brain, Behavior, and Immunity, Vol. 31, p. 9.

    Audet, Marie-Claude Jacobson-Pick, Shlomit McQuaid, Robyn J. and Anisman, Hymie 2013. The Wiley-Blackwell Handbook of Psychoneuroimmunology.

    Dell'Osso, Bernardo Prati, Gianmaria Palazzo, M. Carlotta Rumi, Maria Grazia Cavallaro, Flaminia Aghemo, Alessio Colombo, Massimo and Altamura, A. Carlo 2013. Predictors of Psychopathological Outcome During Peg-Interferon and Ribavirin Therapy in Patients with Chronic HCV-Correlated Hepatitis. Journal of Interferon & Cytokine Research, Vol. 33, Issue. 1, p. 9.

    Raison, C L and Miller, A H 2013. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Molecular Psychiatry, Vol. 18, Issue. 1, p. 15.

    Eccles, Jessica Lallemant, Camille Mushtaq, Farrah Greenwood, Matthew Keller, Majella Golding, Bruno Tibble, Jeremy Haq, Inam and Whale, Richard 2012. Pre-treatment waking cortisol response and vulnerability to interferon α induced depression. European Neuropsychopharmacology, Vol. 22, Issue. 12, p. 892.

    Elovainio, Marko Hurme, Mikko Jokela, Markus Pulkki-Råback, Laura Kivimäki, Mika Hintsanen, Mirka Hintsa, Taina Lehtimäki, Terho Viikari, Jorma Raitakari, Olli T. and Keltikangas-Järvinen, Liisa 2012. Indoleamine 2,3-Dioxygenase Activation and Depressive Symptoms. Psychosomatic Medicine, Vol. 74, Issue. 7, p. 675.

    Maes, Michael Berk, Michael Goehler, Lisa Song, Cai Anderson, George Gałecki, Piotr and Leonard, Brian 2012. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Medicine, Vol. 10, Issue. 1, p. 66.

    McNutt, Marcia D Liu, Shuling Manatunga, Amita Royster, Erica B Raison, Charles L Woolwine, Bobbi J Demetrashvili, Marina F Miller, Andrew H and Musselman, Dominique L 2012. Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine. Neuropsychopharmacology, Vol. 37, Issue. 6, p. 1444.

    Nguyen, Douglas L. and Morgan, Timothy R. 2012. Management of adverse events during the treatment of chronic hepatitis C infection. Clinical Liver Disease, Vol. 1, Issue. 2, p. 54.

    Blacklaws, Helen Gardner, Anne and Usher, Kim 2011. Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C?. Journal of Clinical Nursing, Vol. 20, Issue. 9-10, p. 1215.

    Chopra, Kanwaljit Kumar, Baldeep and Kuhad, Anurag 2011. Pathobiological targets of depression. Expert Opinion on Therapeutic Targets, Vol. 15, Issue. 4, p. 379.

    Kenis, Gunter Prickaerts, Jos van Os, Jim Koek, Ger H. Robaeys, Geert Steinbusch, Harry W. M. and Wichers, Marieke 2011. Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?. The International Journal of Neuropsychopharmacology, Vol. 14, Issue. 02, p. 247.

    Maes, Michael 2011. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, Issue. 3, p. 664.

    Maes, Michael 2011. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, Issue. 3, p. 784.

    Raison, Charles L. and Miller, Andrew H. 2011. Is Depression an Inflammatory Disorder?. Current Psychiatry Reports, Vol. 13, Issue. 6, p. 467.


Early increase in vegetative symptoms predicts IFN-α-induced cognitive-depressive changes

  • M. C. WICHERS (a1), G. H. KOEK (a2), G. ROBAEYS (a3), A. J. PRAAMSTRA (a1) and M. MAES (a1)
  • DOI:
  • Published online: 01 April 2005

Background. The vegetative symptoms of depression resemble the symptoms of malaise associated with activation of the inflammatory response system (IRS), and can be regarded as an expression of a central motivational state that resets the organism's priorities to promote recovery from infection. Early vegetative symptoms, however, may also contribute to the high rates of depression seen later in the course of immune activation. We hypothesized that the onset of vegetative-depressive symptoms early in the treatment with the pro-inflammatory cytokine IFN-α in chronic hepatitis C patients would increase the risk for subsequent depressive cognitions.

Method. Sixteen patients eligible for IFN-α treatment and free of psychiatric disorders were recruited. The DSM-IV, the Multidimensional Fatigue Inventory, and the Montgomery–Asberg Depression Rating Scale (MADRS) were administered at baseline and 1, 2, 4, 8, 12 and 24 weeks after treatment was initiated. Cognitive-depressive and vegetative-depressive symptom clusters were constructed.

Results. Fatigue and depression scores increased significantly during IFN-α treatment. Depression scores were highest at week 8 of treatment. First week increase in vegetative-depressive symptom score predicted cognitive-depressive symptom score at week 8 and at week 24.

Conclusions. During IFN-α treatment, vegetative symptoms of depression appear earlier than, and are predictive of, their cognitive counterparts. This finding suggests that low mood state may in part be driven by the increase in early vegetative-depressive symptoms in the course of IFN-α-induced immune activation.

Corresponding author
Dr M. C. Wichers, Department of Psychiatry and Neuropsychology, Maastricht University, PO Box 616 (PAR 45), 6200 MD Maastricht, The Netherlands. (Email:
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *